In many facets of life, if you want to do something right, you feel inclined to do it yourself. This age old adage is no different for the biopharma industry, especially when it comes to developing home grown clinical software solutions. But now many biopharma companies actually employ an extensive software development team, not to mention enough IT resources and infrastructure to host and maintain the system? And with tighter resources available, is this really where a company’s talent and energy should be focused?
Archive for July, 2012
Commercial launch of a biopharma company’s first drug product is a transformative event. A first product launch includes not only preparing the organization for the transition from development to commercial, but also transforming the IT applications and support model for the company. IT organizations that have been trying to differentiate themselves or increase business presence have a unique opportunity to:
1. Modify current IT practices
2. Pre-plan for commercial needs
3. Support other departments, e.g. G&A, prepare for corporate transition
On June 7, 2012, I presented at the International Society for Pharmaceutical Engineering (ISPE) Supply Networks Conference held in Baltimore, Maryland.
Attendees were mostly ISPE members with backgrounds in technical services, quality, and manufacturing in the pharmaceutical and biotechnology industry. 50% of the audience was big pharma members. Also in attendance were suppliers to pharma and biotech, including API manufacturers. The conference typically targeted discussion of supply chain issues from an educational point of view that most members were not familiar with. Members received educational credits by attending.